NASDAQ · Medical Care Facilities · USD
Astrana Health, Inc. (ASTH) Stock Analysis
Astrana Health, Inc. (ASTH) is a Medical Care Facilities stock listed on NASDAQ and quoted in US Dollar.
Last Updated: October 21, 2026
Price History
No price data available
Hover for the daily close. The dotted line marks the period open.
ASTH Key Statistics
As of Oct 21, 2026Trading
- Open
- $38.74
- Previous Close
- $38.58
- Day's Range
- 37.20–38.74
- 52-Week Range
- 18.08–51.60
- Volume
- 222.91K
- BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
- 1.03
Valuation
- Market Cap
- $1.85B
- P/E Ratio
- 45.00
- Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
- 10.27
- P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
- 0.48
- EPS (ttm)Profit attributable to each share over the last twelve months.
- 0.83
Financials (FY)
- Revenue (FY)
- $3.18B+56.39%
- Net Income (FY)
- $22.49M−47.89%
- Profit marginThe share of revenue left as profit after all costs and taxes.
- 1.05%
- Shares Outstanding
- 49.60M
- 1-Year Return
- +12.60%
Dividend and dates
- Earnings Date
- November 5, 2026
- Avg Volume
- 430.44K
Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.
Key facts
As of October 21, 2026, ASTH closed at $37.35, +12.60% over 1 year.
Astrana Health, Inc. (ASTH) has a market capitalization of $1.85B.
In fiscal 2025, ASTH reported revenue of $3.18B.
ASTH Stock Return by Calendar Year
Astrana Health, Inc. (ASTH) 10-year return: what $10,000 became
- 1 year
- $10,000 $11,260
- +12.60%
- 5 years
- $10,000 $5,193
- −48.07%
- 10 years
- $10,000 $99,600
- +896.00%
If you had invested $10,000 in Astrana Health, Inc. (ASTH) 10 years ago, at the close on October 21, 2016, it would have been worth $99,600 at the close on October 21, 2026: +896.00% in total, +25.84% a year. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.
Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.
| Year | Return |
|---|---|
| 2026 (partial year) | +50.54% |
| 2025 | −21.31% |
| 2024 | −17.68% |
| 2023 | +29.44% |
| 2022 | −59.73% |
| 2021 | +302.19% |
| 2020 | −0.76% |
| 2019 | −7.25% |
| 2018 | −17.29% |
| 2017 | +220.00% |
| 2016 (partial year) | +56.58% |
As of October 21, 2026.
ASTH Revenue and Earnings by Fiscal Year
FY ends December| Fiscal year | Revenue | Net income | Net margin |
|---|---|---|---|
| 2025 | $3.18B | $22.49M | 0.7% |
| 2024 | $2.03B | $43.15M | 2.1% |
| 2023 | $1.39B | $60.72M | 4.4% |
| 2022 | $1.14B | $45.17M | 3.9% |
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| 2025 | $3.18B | $341.53M | $78.53M | $22.49M | 0.7% |
| 2024 | $2.03B | $271.39M | $89.35M | $43.15M | 2.1% |
| 2023 | $1.39B | $214.96M | $84.61M | $60.72M | 4.4% |
| 2022 | $1.14B | $199.48M | $104.27M | $45.17M | 3.9% |
Annual figures as reported, in the company's reporting currency. As of December 31, 2025.
ASTH Valuation vs Medical Care Facilities Median
Median of 54 stocks| Metric | ASTH | Medical Care Facilities median | vs median |
|---|---|---|---|
| P/E | 45.00 | 20.67 | 118% above |
| P/S ratio | 0.48 | 0.87 | 45% below |
| Profit margin | 1.05% | 3.19% | 2.1 pts below |
Medians across 54 Medical Care Facilities stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.
Recent News
Alignment Health Plan and Astrana Health Partner to Expand Access to Trusted Local Care for California Seniors
YahooIs Astrana Health (ASTH) Undervalued Following Its Verda Healthcare Partnership?
YahooHow Investors May Respond To Astrana Health (ASTH) Expanding Culturally Tailored Care In Underserved U.S. Communities
YahooAstrana Health (ASTH) Stock Could Look Fully Priced On New Multi State Partnership
YahooVerda Healthcare, Inc. and AstranaCare Partners Form a Multi-State Partnership
YahooAstrana Health, Inc. Schedules 2026 Third Quarter Financial Results Release and Conference Call
Yahoo
All 20 articles ↓Show fewer ↑
Why Astrana Health, Inc. (ASTH) is Poised to Beat Earnings Estimates Again
YahooAstrana Health (ASTH): Buy, Sell, or Hold Post Q2 Earnings?
YahooHealthcare Technology for Providers Stocks Q2 In Review: Astrana Health (NASDAQ:ASTH) Vs Peers
YahooWhy Astrana Health (ASTH) Shares Are Trading Lower Today
YahooAstrana Health Affirms FY2026 Sales Guidance of $3.800B-$4.100B vs $4.004B Est
BenzingaAstrana Health Says Cybersecurity Incident Is Material After Unauthorized Data Access, Does Not Expect Material Financial Impact
BenzingaWatching Astrana Health; Glass House Research Issues Report On Co Stating It Holds A Short Position
BenzingaAstrana Health, Clover Health, Alignment Healthcare, and Novavax Stocks Trade Down, What You Need To Know
YahooOppenheimer Initiates Coverage On Astrana Health with Outperform Rating, Announces Price Target of $53
BenzingaAstrana Health: 81% Full-Risk And Profitable
SeekingAlphaTruist Securities Maintains Buy on Astrana Health, Raises Price Target to $55
BenzingaBarclays Maintains Overweight on Astrana Health, Raises Price Target to $53
BenzingaAstrana Health, Inc. (ASTH) Q2 2026 Earnings Call Transcript
SeekingAlphaAstrana Health (NASDAQ:ASTH) Falls on Q2 Revenue Miss Despite Earnings Beat
ChartMill
News provided by third-party sources. Not financial advice.
Analysis
Data-derivedEvery figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.
Related Medical Care Facilities Stocks
HCA Healthcare, Inc.
$99.46B
THCTenet Healthcare Corporation
$21.67B
EHCEncompass Health Corporation
$11.88B
FMSFresenius Medical Care AG
$11.47B
DVADaVita Inc.
$11.28B
UHSUniversal Health Services, Inc.
$10.78B
Popular Healthcare Stocks
Eli Lilly and Company
$1.13T
JNJJohnson & Johnson
$621.22B
ABBVAbbVie Inc.
$503.27B
UNHUnitedHealth Group Incorporated
$374.30B
MRKMerck & Co., Inc.
$369.78B















